Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Amicus Therapeutics Inc (NASDAQ: FOLD) closed at $10.68 down -0.28% from its previous closing price of $10.71. In other words, the price has decreased by -$0.28 from its previous closing price. On the day, 2.21 million shares were traded. FOLD stock price reached its highest trading level at $10.805 during the session, while it also had its lowest trading level at $10.52.
Ratios:
For a deeper understanding of Amicus Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.26 and its Current Ratio is at 2.75. In the meantime, Its Debt-to-Equity ratio is 3.35 whereas as Long-Term Debt/Eq ratio is at 3.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on September 06, 2024, initiated with a Buy rating and assigned the stock a target price of $18.
On May 30, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $18.
Guggenheim Upgraded its Neutral to Buy on May 14, 2024, while the target price for the stock was maintained at $13.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 03 ’24 when Campbell Bradley L sold 7,500 shares for $11.71 per share. The transaction valued at 87,798 led to the insider holds 886,654 shares of the business.
BRADLEY CAMPBELL bought 7,500 shares of FOLD for $87,075 on Sep 03 ’24. On Aug 01 ’24, another insider, Campbell Bradley L, who serves as the President and CEO of the company, sold 7,500 shares for $10.34 each. As a result, the insider received 77,518 and left with 886,654 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FOLD now has a Market Capitalization of 3167591936 and an Enterprise Value of 3351587072. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.95 while its Price-to-Book (P/B) ratio in mrq is 23.89. Its current Enterprise Value per Revenue stands at 7.356 whereas that against EBITDA is -200.898.
Stock Price History:
Over the past 52 weeks, FOLD has reached a high of $14.57, while it has fallen to a 52-week low of $9.02. The 50-Day Moving Average of the stock is -3.34%, while the 200-Day Moving Average is calculated to be -6.53%.
Shares Statistics:
For the past three months, FOLD has traded an average of 2.57M shares per day and 2797440 over the past ten days. A total of 293.59M shares are outstanding, with a floating share count of 289.03M. Insiders hold about 2.55% of the company’s shares, while institutions hold 105.21% stake in the company. Shares short for FOLD as of 1726185600 were 22808015 with a Short Ratio of 8.87, compared to 1723680000 on 24042394. Therefore, it implies a Short% of Shares Outstanding of 22808015 and a Short% of Float of 7.739999999999999.
